Gardasil 9, cjepivo protiv humanog papilomavirusa (rekombinantno, adsorbirano)
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Gardasil 9, cjepivo protiv humanog papilomavirusa (rekombinantno, adsorbirano) |
|---|---|
| Active Substance | L1 protein humanog papilomavirusa tip 6 L1 protein humanog papilomavirusa tip 11 L1 protein humanog papilomavirusa tip 16 L1 protein humanog papilomavirusa tip 18 L1 protein humanog papilomavirusa tip 31 L1 protein humanog papilomavirusa tip 33 L1 protein humanog papilomavirusa tip 45 L1 protein humanog papilomavirusa tip 52 L1 protein humanog papilomavirusa tip 58 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| ATC Code | J07BM03 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
